Promoting tuberculosis preventive therapy in HIV
- PMID: 35908552
- DOI: 10.1016/S2352-3018(22)00197-7
Promoting tuberculosis preventive therapy in HIV
Conflict of interest statement
We declare no competing interests. SML reports grant funding from Merck outside the submitted work. We would like to acknowledge Grace John-Stewart (University of Washington) for comments on the manuscript.
Comment on
-
A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in Uganda: a cluster randomised trial.Lancet HIV. 2022 Sep;9(9):e607-e616. doi: 10.1016/S2352-3018(22)00166-7. Epub 2022 Jul 28. Lancet HIV. 2022. PMID: 35908553 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical